Biogen Inc banner

Biogen Inc
XHAM:IDP

Watchlist Manager
Biogen Inc Logo
Biogen Inc
XHAM:IDP
Watchlist
Price: 158.16 EUR 2.03% Market Closed
Market Cap: €23B

Revenue Breakdown

Breakdown by Geography
Biogen Inc

Not Available

Breakdown by Segments
Biogen Inc

Total Revenue: 9.9B USD
100%
Reportable Segment: 9.7B USD
97.8%
Product Revenue, Net: 7.2B USD
72.9%
Subtotal: Multiple Sclerosis: 4.3B USD
44%
Subtotal: Rare Disease: 2B USD
20.1%
Revenue From Anti-Cd20 Therapeutic Programs: 1.7B USD
17.7%
Total Fumarate: 1.6B USD
16.1%
Spinraza: 1.6B USD
15.9%
Royalty Revenue On Sales Of Ocrevus: 1.3B USD
13.5%
Total Interferon: 968m USD
9.8%
Subtotal: Biosimilars: 793.1m USD
8%
Contract Manufacturing, Royalty And Other Rev...: 652.6m USD
6.6%
Vumerity: 628m USD
6.3%
Contract Manufacturing Revenue: 592.1m USD
6%
Other: 82.5m USD
0.8%
Royalty And Other Revenue: 60.5m USD
0.6%
Alzheimer's Collaboration Revenue: 59.9m USD
0.6%
Qalsody: 32.4m USD
0.3%
Show More
Show Less
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett